Search Results

If your project involves GPCRs , functional selectivity , or non-traditional ligands , this session is Function: Two Different Worlds One of the most common—and dangerous—mistakes in allosteric pharmacology When a PAM increases radioligand binding but suppresses functional response, it’s not broken pharmacology—it The takeaway:  what looks like pharmacology failure may be a systems problem . Terry Kenakin An always-growing library of on-demand pharmacology insights The ability to vote on or

Congrats to the GPCR Therapeutics team for their recent paper in the American College of Clinical Pharmacology GPCR Symposium on 'GPCRs as Therapeutic Modalities'. ' latest science paper was published by the American College of Clinical Pharmacology Sosei and Cancer Postdoc Research Associate Director, Regulatory Affairs Research Scientist/Senior Scientist I - Molecular Pharmacology GPCR Ecosystem

Despite considerable advances in pharmacological treatment, HF represents a severe clinical and social In this review, we discuss important aspects of adrenal GPCR signaling and regulation, as they pertain modulation of cardiac function in the context of chronic HF, by focusing on the 2 best studied adrenal GPCR the β-arrestins in the adrenals, 2 protein families that regulate the signaling and functioning of GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews

are small-lipidated peptides designed from the intracellular loops of G protein-coupled receptors (GPCRs ) that act in an allosteric manner to modulate the activity of GPCRs. Over the past 2 decades, pepducins have progressed initially from pharmacologic tools used to manipulate GPCR activity in an orthosteric site-independent manner to compounds with therapeutic potential that Read more at the source #DrGPCR #GPCR #IndustryNews

Hello GPCR enthusiasts! Check out the latest advancements in GPCR studies. Save the date! GPCR Symposium on 'GPCRs as Therapeutic Modalities'. Want to share your project in a casual way? GPCR Newsletter! Postdoc Research Associate Director, Regulatory Affairs Research Scientist/Senior Scientist I - Molecular Pharmacology GPCR Ecosystem

Read more at the source #DrGPCR #GPCR #IndustryNews

Read more at the source #DrGPCR #GPCR #IndustryNews

2022 Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR the Sosei Heptares compound library for its industry-leading biology platform to identify potential GPCR entered a strategic research collaboration to identify and validate novel G protein-coupled receptor (GPCR drug discovery programs in the area of gastrointestinal diseases. " Read more at the source #DrGPCR #GPCR

Welcome, GPCR enthusiasts! This week's GPCR papers feature a publication by Dr. Robert J Lefkowitz. GPCR Symposium on Structural and Molecular Insights on GPCR Activation! GPCR Newsletter for updates! Postdoctoral Fellow, Caron Lab Clinical Trial Associate Research Scientist/Senior Scientist I - Molecular Pharmacology GPCR Ecosystem

Hello GPCR enthusiasts! We're here to share the latest GPCR news with you. Congratulations to Dr. GPCR Newsletter for updates! /Senior Scientist I - Molecular Pharmacology Vice President, Medical Affairs Associate Director / Director , Clinical Operations Professor in Cardiovascular Pharmacology Explore Dr. GPCR Ecosystem

transcription is endocytosis-dependent in primary hepatocytes "A number of G protein-coupled receptors (GPCRs activation by glucagon within 5 min and transit via EEA1-marked endosomes shown previously to be sites of GPCR Read more at the source #DrGPCR #GPCR #IndustryNews

Read more at the source #DrGPCR #GPCR #IndustryNews

August 2022 "The cannabinoid CB1 receptor is the most abundant G protein coupled receptor (GPCR) in LINKED ARTICLES: This article is part of a themed issue on Structure Guided Pharmacology of Membrane Proteins (BJP 75th Anniversary). " Read more at the source #DrGPCR #GPCR #IndustryNews

Welcome, GPCR buffs! Join us for our weekly round-up of GPCR News. Congratulations to our Dr. GPCR Symposium on Structural and Molecular Insights on GPCR Activation. Signalling (June 30 - July 1, 2023) 19th World Congress of Basic & Clinical Pharmacology 2023. - 29, 2024) GPCR Jobs Professor in Cardiovascular Pharmacology Scientist I / Scientist II DOE (Native GPCR Ecosystem

Greetings GPCR enthusiasts! Join us to explore the fascinating world of GPCRs. GPCR Symposium on Structural and Molecular Insights on GPCR Activation. Signalling (June 30 - July 1, 2023) 19th World Congress of Basic & Clinical Pharmacology 2023. (March 24 - 29, 2024) GPCR Jobs NEW Professor in Cardiovascular Pharmacology Scientist I / Scientist GPCR Ecosystem

Hi there GPCR enthusiasts! Join us this week for a deep dive into the world of GPCRs. GPCR Symposium on Structural and Molecular Insights on GPCR Activation. Berchiche is at the Molecular Pharmacology GRC, if you are also on-site, please stop by and say hi. 1, 2023) 19th World Congress of Basic & Clinical Pharmacology 2023. GPCR Ecosystem

August 2022 A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology monitor the activation state of G protein-coupled receptors are a useful addition to the molecular pharmacology Read more at the source #DrGPCR #GPCR #IndustryNews

This week, we've curated 12 GPCR papers. GPCR Symposium for the year, which will focus on GPCRs in Immunology and Oncology. in Medicinal Chemistry NEW July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology Antibody Discovery Staff Scientist (AC-TAP) in Database Development at Department of Drug Design and Pharmacology GPCR Ecosystem

Good day, GPCR folks! Take advantage of our GPCR highlights of the week. Dr. GPCR Symposium for the year on GPCRs in Immunology and Oncology! Antibody Discovery Staff Scientist (AC-TAP) in Database Development at Department of Drug Design and Pharmacology Medical Sciences Octant Apprentice Head of Human Resource Business Partners Senior Scientist, In vitro pharmacology - Crinetics Pharmaceuticals Senior Director, In vitro pharmacology - Crinetics Pharmaceuticals Explore

β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the same GPCR cells "β-arrestins mediate regulatory processes for over 800 different G protein-coupled receptors (GPCRs ) by adopting specific conformations that result from the geometry of the GPCR-β-arrestin complex. However, whether β-arrestin1 and 2 respond differently for binding to the same GPCR is still unknown. Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter

November 2022 "Despite the growing number of G protein-coupled receptor (GPCR) structures, only 39 structures The method has found druggable sites overlapping with the cocrystallized allosteric ligands in 21 GPCR We then mapped the 394 GPCR X-ray structures available at the time of the analysis (September 2020). Results show that for each of the 21 structures with bound ligands there exist many other GPCRs that Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE

Hi GPCR lovers👋, Ready for exciting news in the GPCR world? Read them below! GPCRs in Cardiology, Endocrinology, and Taste Pathophysiology and pharmacology of G protein-coupled receptors (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). 1, 2023) 19th World Congress of Basic & Clinical Pharmacology 2023. GPCR Ecosystem

Notably, G-protein-coupled receptors (GPCRs), representing the biggest drug target, have been revealed Historically, drug discovery efforts targeting GPCRs focused on G-protein-dependent signaling pathways In summary, targeting GPCR-activated ERK pathways represents a promising strategy for developing new Minireview: targeting GPCR activated ERK pathways for drug discovery. Pharmacological Reviews, 71(2), 267-315. Lu, N., & Malemud, C. J. (2019).

August 2022 RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. GPCRs are involved in a variety of physiological and pathophysiological processes. So far, numerous therapeutics targeting GPCRs have been developed, with a focus on small molecules and Recently, functional autoantibodies targeting GPCRs have been associated with various disease-specific Read more at the source #DrGPCR #GPCR #IndustryNews

Hi GPCR buffs 👋! This week's GPCR papers feature a publication from Dr. Marta Filizola. GPCR Symposium on GPCR Activation and Signaling was a great success. (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). 1, 2023) 19th World Congress of Basic & Clinical Pharmacology 2023. GPCR Ecosystem

November 2022 "Recently determined structures of class C G protein-coupled receptors (GPCRs) revealed treatment of psychiatric and neurodegenerative diseases, and several allosteric modulators of this GPCR libraries have complementary advantages and illustrate how access to high-resolution structures of GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE

Hi GPCR lovers! Stay tuned for the latest buzz on GPCRs. and Pharmacological Implications. American Society for Pharmacology and Experimental Therapeutics (May 18 - 21, 2023). (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). 1, 2023) 19th World Congress of Basic & Clinical Pharmacology 2023.

Originally, β-arrestins were identified for their contribution to GPCR desensitization to agonist-mediated However, current investigations have now recognized that in addition to GPCR arresting (hence the name Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE

Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Symposium on GPCR Activation and Signaling. ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics (May 18 - 21, 2023). (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). 1, 2023) 19th World Congress of Basic & Clinical Pharmacology 2023. GPCR Ecosystem